Intelomed, Inc.
8
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 100/100
37.5%
3 terminated/withdrawn out of 8 trials
57.1%
-29.4% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Measuring Cardiovascular Stress in Patients on Hemodialysis Study II
Role: lead
mCVI Confirmatory Clinical Study: Algorithm Verification With Healthy Volunteers
Role: lead
Cardiovascular and Respiratory Assessment Using Biometric Signals in a Non-contact Monitoring Device
Role: collaborator
mCVI® Lighting Conditions Clinical Study
Role: lead
mCVI Pilot Study: Algorithm Verification
Role: lead
mCVI Confirmatory Clinical Study: Algorithm Verification
Role: lead
Pilot Study Using a Pulse Oximeter Derived Photo-plethysmographic Waveform to Guide Hemodialysis Ultrafiltration
Role: lead
Correlating Noninvasive Cardiovascular Measures to Left Ventricular End Diastolic Pressure in Heart Failure
Role: lead
All 8 trials loaded